VoyForums: Hepatitis C Outreach Project

Oklahoma Disaster Relief

American Red Cross
Together, we can save a life

See Kare11.com's page for more ways to contribute.

VoyForums Notice -- Quick Contributions:
Donate $10 to the Red Cross: Text the word REDCROSS to 90999
Donate $10 to the Salvation Army: Text the word STORM to 80888
* The charge will appear on your cellphone bill.

Thu, May 23 2013, 0:05:38 PDT [ VoyUser Login optional ] [ Main index ] [ Post a new message ] [ Search | Check update time | Archives: 1, 2, 3, [4], 5 ]

Hepatitis C Outreach Project, (since 1992) Discussion Forum
Our mission is to inspire, support and enhance community efforts toward prevention, awareness, education, and treatment of hepatitis C and promote organ donation. We are committed to working with any organization, agency, or professional individual to develop partnerships resulting in quality programing and good public decision making based on accurate information regarding hepatitis C. We offer our resources and services freely in a spirit of goodwill and generosity, ever mindful of our purpose.

Information on health issues concerning hepatitis C. The information is intended to assist professionals with clinical decisions and provide background information for presentations. It is not intended as a substitute for medical advice from a practitioner.
Please remember the Hepatitis C Outreach Project in your Workplace Giving Campaigns this fall
As fall is upon us, so too are the workplace fund drives. Hepatitis C is proud to participate in employee giving programs that allow donations through payroll deduction.
Please consider Hepatitis C when making your contribution this fall.
Many state governments have charitable fund drives for their employees. Each state has its own eligibility criteria. If you wish to designate the Hepatitis C Outreach Project for your contributions and your state requires information or documentation, please contact us and let us know what we need to do to qualify for your fund drive.
Some United Way campaigns allow unlisted charities to receive your contribution. If Hepatitis C Outreach Project is not listed in your United Way brochure, you may still be able to contribute through the "Donor Option" feature that many local United Ways now offer. If your local has the donor option, write the Hepatitis C Outreach name and address in the space provided on your United Way pledge card:
Hepatitis C Outreach Project
Tax ID: 91-1909632

Finally, many corporate giving campaigns allow a donor to write in a charity of choice. Lists are often provided of eligible organizations, but the list is not limited. You can still designate the Hepatitis C Outreach Project as your choice this year simply by writing the above information into the space provided.
The Hepatitis C Outreach Project is very grateful for our past contributors and we hope that you will continue to support our mission in the fall 2009 pledge drive in your community.
We are a 501(c)3 charitable organization under the Internal Revenue Service Tax Code. We are listed with Guidestar.org, verified by facebook.
Back to HCOP site

Subject	Author	Date
The APHA Standards for Health Care in Correctional Institutions Revised	American Public Health Association	Sun, March 04 2001, 7:56:54 PST
assessing intraprison transmission -- Christopher M. Salas, et al, Sun, March 04 2001, 8:00:29 PST Trends in hepatitis C and HIV infection among inmates entering prisons in California, 1994 versus 1999 -- AIDS November 2002; 16(16):2236-2238, Sun, October 27 2002, 10:04:57 PST
FDA Approves Pegasys (Peginterferon Alfa-2a) For the Treatment of Hepatitis C	SOURCE: Hoffmann-La Roche Inc.	Wed, October 23 2002, 3:56:13 PDT
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. -- Fried MW, et al N Engl J Med 2002 Sep 26;347(13):975-82, Wed, October 23 2002, 4:00:56 PDT
High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study	Abstract Volume 37 Issue 9 (2002) pp 732-736 J of Gastroenterology	Wed, October 23 2002, 3:52:40 PDT
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.	Regev A, et al Am J Gastroenterol 2002 Oct;97(10):2614-8	Mon, October 21 2002, 19:37:33 PDT
Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study.	Heemann U, et al. Hepatology 2002 Oct;36(4 Pt 1):949-58	Wed, October 16 2002, 11:53:19 PDT
Empirically Calibrated Model of Hepatitis C Virus Infection in the United States	Am. J. Epidemiol 2002-- Salomon et al. 156 (8): 761-773	Wed, October 16 2002, 4:07:20 PDT
References (Empirically Calibrated Model of Hepatitis C Virus Infection in the United States) -- Salomon et al, Am J Epidemiol 2002; 156:761-773., Wed, October 16 2002, 4:11:21 PDT
A DGReview of :"HIV and HCV Infection among Injecting Drug Users"Mt Sinai J Med 2000; 67: 423-428.	Review by James Adams	Sat, March 03 2001, 11:18:05 PST
Sharing of Drug Preparation Equipment as a Risk Factor for Hepatitis C -- HAGAN, Am Jour of Pub Hlth 43 Jan 2001, Vol. 91, No.1, Thu, January 10 2002, 7:04:38 PST IV Drug Users with Hepatitis C Don't Play It Safe -- Reuters Health: Clinical Infectious Diseases 2002;35:783-788, Tue, October 15 2002, 7:03:22 PDT
Induction therapy with consensus interferon (CIFN) does not improve SVR	Layden TJ, et al J Viral Hepat 2002 Sep;9(5):334-9	Wed, September 25 2002, 6:42:48 PDT
adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis C -- Gaeta GB, et al Aliment Pharmacol Ther 2002 Sep;16(9):1633-9, Wed, September 25 2002, 7:05:20 PDT
Safety and efficacy of histamine dihydrochloride and interferon-alpha-2b	Lurie Y, et al J Viral Hepat 2002 Sep;9(5):346-353	Wed, September 25 2002, 6:39:37 PDT
Hepatitis C Outreach Project on Tattooing	HA Aronow, MD Medical Director & Teresa Hanbey Exec Director	Mon, March 25 2002, 11:50:54 PST
Careless tattooing linked to spread of hepatitis C -- Fran Henry Plain Dealer Reporter, Cleveland , Ohio, Mon, September 23 2002, 16:23:26 PDT
Interferon: Evolution	MD ANDERSON ONCOL Volume 39, Number 4 (Oct-Dec 1994)	Thu, September 19 2002, 10:31:40 PDT
University of Pittsburgh Receives $7.7 Million to Lead a Study on Racially Based Differences in.....	PRNewswire	Wed, October 10 2001, 9:03:47 PDT
African Americans with genotype 1 treated with ......... -- Kinzie JL, Naylor PH Wayne State University School of Med, Wed, December 19 2001, 6:05:43 PST Racial differences in responses to therapy ......... -- Reddy KR, Hoofnagle JH University of Miami, Wed, December 19 2001, 6:08:00 PST The impact of interferon plus ribavirin ....... -- McHutchison JG, Poynard T Scripps Clinic and Research Foun.., Wed, December 19 2001, 6:11:43 PST Severity and correlates of liver disease in (African American)HCV–infected IVDU's -- Rudra Rai, et al HEPATOLOGY 2002;35:1247-1255.), Wed, May 22 2002, 4:22:34 PDT Virahep-C -- Hepatology Sept 2002, Vol 36, Number 3, Sat, September 14 2002, 8:52:36 PDT
The Meaning and Significance of the Supreme Court’s ruling: Echazabal	Jon Davidson, Senior Counsel, Lambda Legal Defense........	Thu, June 13 2002, 3:42:23 PDT
Re: The Meaning and Significance of the Supreme Court’s ruling: Echazabal -- Debbie, Wed, September 11 2002, 12:18:23 PDT Response -- John Davidson, Senior Counsel Lambda Legal Defense..., Fri, September 13 2002, 17:00:06 PDT
Oldest Non-Profit Hepatitis C Organization Applauds New Draft NIH	PRNewswire	Tue, June 18 2002, 20:16:34 PDT
FINAL DRAFT of NIH Consensus Conference on HCV now online -- http://consensus.nih.gov/cons/116/116cdc_statement.htm, Tue, September 03 2002, 10:16:51 PDT
Over-the-Counter Drug Products Containing Colloidal Silver Ingredients or Silver Salts	Food and Drug Administration, HHS. (Final Rule)	Sun, August 11 2002, 5:03:48 PDT
HIV Linked to Pathogenesis of Hepatitis C-Related Fibrosis	Michael Smith	Wed, July 24 2002, 11:51:58 PDT
Hepatitis C Has Negative Effect on Long-Term Outcome in Renal Allograft Recipients	Lynda Jackson (DG Report)	Wed, July 24 2002, 11:50:15 PDT
Report: Viral hitchhiker points to new drug targets	Paul Targett-Adams	Wed, July 24 2002, 11:39:37 PDT
Thyroid dysfunction during treatment of chronic hepatitis C	Dalgard, et al J Intern Med 2002; 251: 400-406	Wed, July 24 2002, 11:33:08 PDT
Ford Hospital warns patients about hepatitis testing instruments possibly contaminated	BY PATRICIA ANSTETT AND HUYI JIN ELIZABETH KIM	Tue, June 25 2002, 10:07:32 PDT
Are your patients using Liverite?	FTC settlement announcement: No Scientific Evidence	Wed, August 22 2001, 22:47:46 PDT
The FDA Safety Information - interferon alfa, rebetron, roferon	2002 Safety Information Summaries	Wed, March 27 2002, 19:21:11 PST
Propranolol ameliorates thrombocytopenia in cirrhosis	Kenji Sakai J Gastro Abst Vol 37 Issue 2 (2002) pp 112-118	Wed, March 20 2002, 9:10:48 PST
Haemodynamic effects of admin of carvedilol in patients with cirrhosis and portal hypertension	D. Tripathi, et al ; Alimentary Pharm & Ther (March 2002 )	Wed, March 20 2002, 9:03:54 PST
Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines	Siler CA, (Virology 2002 Jan 5;292(1):24-34 )	Tue, March 12 2002, 7:49:57 PST
Impairment of metabolic function in chronic hepatitis C	Jorquera F, et al Am J Gastroenterol 2001 Aug;96(8):2456-61	Fri, August 24 2001, 15:52:34 PDT
Prognostic value of energy metabolism in patients with viral liver cirrhosis1 -- Tajika MD, et al in Journal of Nutrition (March 2002), Fri, March 08 2002, 11:20:59 PST*
Relationship of HRQOL to Treatment Adherence and Sustained Response in CHC	David Bernstein, MD, (NSUH) in Manhasset, New York	Tue, March 05 2002, 8:37:19 PST
Alcohol and hepatitis C	Jmelnitzky AC.Acta GastroenterolLatinoam 2001 Mar;31(1):37-8	Thu, June 14 2001, 20:00:05 PDT
Women Pay Heavy Price for Alcohol Abuse -- Nancy A. Melville, HealthScoutNews, Sat, January 12 2002, 12:13:01 PST Report on Article: "A Profile of Neuropsychological Deficits in Alcoholic Women," -- DGNEWS, Sat, January 19 2002, 14:48:08 PST
Tissue viral load variability in chronic hepatitis C.	Fanning L Am J Gastroenterol 2001 Dec;96(12):3384-9	Tue, January 08 2002, 5:36:05 PST
Nuclear Factor Kappa B Key Tied To Hepatitis C Severity -- Elias Toubi ,Journal of Hepatology, Vol. 35 (6) (2001), Sat, January 19 2002, 13:13:29 PST Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with HCV infect.. -- Eiji Hinoshita, Journal of Hepatology, Vol. 35 (6) (2001), Sat, January 19 2002, 13:18:34 PST
The natural course of hepatitis C virus infection after 22 years	Barrett S, Goh J et al Gut 2001 Sep;49(3):423-30	Fri, August 24 2001, 15:49:40 PDT
Simulation of hepatitis C based on a mandatory reporting system. -- Sagmeister M, Eur J Gastroenterol Hepatol 2002 Jan, Sat, January 19 2002, 9:43:24 PST
The Art of Getting Hepatitis C	E'Louise Ondash (Healthscout)	Mon, April 09 2001, 10:39:22 PDT
Hepatitis C:Recent findings on risk; testing asymptomatic populations; and preventive messages	HanbeyT, HaleyR, Weeks,K	Sat, May 19 2001, 10:48:39 PDT
Body Piercing a Pain for Some -- MAYO CLINIC, ROCHESTER, Minn. (Reuters), Sat, January 12 2002, 7:06:43 PST

[ Archives: 1, 2, 3, [4], 5 ]

If you have questions or wish to add to the articles, please contact us at info@hcop.org Check "archives" at upper right to access more information. Requests for specific reseach information by email:
info@hcop.org.

Forum timezone: GMT-8
VF Version: 2.94, ConfDB:
Before posting please read our privacy policy.
VoyForums^(tm) is a Free Service from Voyager Info-Systems.
Copyright © 1998-2012 Voyager Info-Systems. All Rights Reserved.